메뉴 건너뛰기




Volumn 19, Issue 1, 2002, Pages 63-66

Could publication of bioinequivalence data discourage frauds on bioequivalence trials?

Author keywords

Bioequivalence; Bioinequivalence; Frauds; Generic drugs

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; DIAZEPAM; DIGOXIN; DILTIAZEM; ESTROGEN DERIVATIVE; GENERIC DRUG; HYDROCHLOROTHIAZIDE;

EID: 0036275666     PISSN: 10601333     EISSN: None     Source Type: Journal    
DOI: 10.1081/CRP-120004217     Document Type: Article
Times cited : (1)

References (17)
  • 2
    • 0000562299 scopus 로고    scopus 로고
    • In vivo bioequivalence guidances
    • United States Pharmacopoeia XXIII
    • (1998) General Information , Issue.SUPPL. 8 , pp. 4382-4426
  • 3
    • 0032825293 scopus 로고    scopus 로고
    • Open questions on bioequivalence: Some problems and some solutions
    • (1999) Pharmacol. Res. , vol.40 , pp. 357-368
    • Marzo, A.1
  • 4
    • 0022424933 scopus 로고
    • Scientific fraud probed at AAAS Meeting
    • (1985) Science , vol.228 , pp. 1292-1293
    • Smith, R.J.1
  • 16
    • 0030945273 scopus 로고    scopus 로고
    • Bioequivalence of levothyroxine preparations: Industry sponsorship and academic freedom
    • (1997) J. Am. Med. Assoc. , vol.277 , pp. 1200-1201
    • Eckert, C.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.